Page 3 - நிறுவனம் போ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Home / Top News / Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices NEWTOWN, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today provided comments in response to a press release issued by the Centers for Medicare & Medicaid Services (“CMS”) on Tuesday, January 12, 2021. In the press release, CMS stated that it is finalizing a new Medicare coverage pathway, Medicare Coverage of Innovative Technology, or “MCIT,” for Food and Drug Administration (“FDA”)-designated breakthrough medical devices. The MCIT rule will provide national

United statesJack powellDane andreeffCompany poCenters for medicare medicaid servicesEuropean union or australiaHelius medical technologies incDrug administrationMedicare coverage of innovative technologyExchange commissionCompany annual report on formToronto stock exchangeEuropean unionTherapeutic goods administrationHelius medical technologiesMedicaid services